source
- Science Corp's retinal implant gains European approval, eyesight aid for macular degeneration patientsScience Corporation announced that European regulators have approved its retinal implant for patients with age-related macular degeneration. The device, described as a 'cochlear implant for vision…
- Royalty Pharma pays $125M upfront for royalty stake in AstraZeneca’s ATTR drug cliramitugRoyalty Pharma has entered a deal to acquire a royalty interest in a transthyretin amyloidosis drug being developed by AstraZeneca. The agreement involves an upfront payment of $125 million to Neu…